Found: 72
Select item for more details and to access through your institution.
47XXY and 47XXX in Scleroderma and Myositis.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 6, p. 528, doi. 10.1002/acr2.11413
- By:
- Publication type:
- Article
Postlicensure Safety Surveillance for Varicella Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2000, v. 284, n. 10, p. 1271, doi. 10.1001/jama.284.10.1271
- By:
- Publication type:
- Article
Developing international consensus on measures of improvement for patients with myositis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fitness as a Determinant of the Oxygen Uptake/Work Rate Slope in Healthy Children and Children With Inflammatory Myopathy.
- Published in:
- Canadian Journal of Applied Physiology, 2003, v. 28, n. 6, p. 888, doi. 10.1139/h03-063
- By:
- Publication type:
- Article
Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology.
- Published in:
- Pediatric Rheumatology, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12969-018-0261-x
- By:
- Publication type:
- Article
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.
- Published in:
- Pediatric Rheumatology, 2017, v. 14, p. 1, doi. 10.1186/s12969-016-0134-0
- By:
- Publication type:
- Article
Gene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142486
- By:
- Publication type:
- Article
Post-Zygotic and Inter-Individual Structural Genetic Variation in a Presumptive Enhancer Element of the Locus between the <i>IL10Rβ</i> and <i>IFNAR1</i> Genes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0067752
- By:
- Publication type:
- Article
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 10, p. 4095, doi. 10.1007/s10067-021-05730-7
- By:
- Publication type:
- Article
Association of Ultraviolet Radiation Exposure With Dermatomyositis in a National Myositis Patient Registry.
- Published in:
- Arthritis Care & Research, 2020, v. 72, n. 11, p. 1636, doi. 10.1002/acr.24059
- By:
- Publication type:
- Article
Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 5, p. 732, doi. 10.1002/acr.22212
- By:
- Publication type:
- Article
Confusion Concerning Multiple Versions of the Childhood Myositis Assessment Scale.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 4, p. 648, doi. 10.1002/acr.22239
- By:
- Publication type:
- Article
Clinical and Laboratory Features Distinguishing Juvenile Polymyositis and Muscular Dystrophy.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 12, p. 1969, doi. 10.1002/acr.22088
- By:
- Publication type:
- Article
Patient outcomes in rheumatology, 2011: a review of measures. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
- Published in:
- 2011
- By:
- Publication type:
- journal article
Parvovirus B19 and Onset of Juvenile Dermatomyositis.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Myositis: Immunologic contributions to understanding cause, pathogenesis, and therapy.
- Published in:
- Annals of Internal Medicine, 1995, v. 122, n. 9, p. 715, doi. 10.7326/0003-4819-122-9-199505010-00010
- By:
- Publication type:
- Article
Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0732-0
- By:
- Publication type:
- Article
Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 238, doi. 10.1186/s13075-015-0732-0
- By:
- Publication type:
- Article
Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 6, p. 3506, doi. 10.1186/ar3506
- By:
- Publication type:
- Article
Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of a computed tomography calcium scoring technique for assessing calcinosis distribution, pattern and burden in dermatomyositis.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 58, doi. 10.1093/rheumatology/kead256
- By:
- Publication type:
- Article
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3757, doi. 10.1093/rheumatology/kead203
- By:
- Publication type:
- Article
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
- Published in:
- Rheumatology, 2023, v. 62, n. 11, p. 3672, doi. 10.1093/rheumatology/kead110
- By:
- Publication type:
- Article
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. 3161, doi. 10.1093/rheumatology/kead033
- By:
- Publication type:
- Article
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2864, doi. 10.1093/rheumatology/keac687
- By:
- Publication type:
- Article
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
- Published in:
- Rheumatology, 2023, v. 62, p. SI226, doi. 10.1093/rheumatology/keac428
- By:
- Publication type:
- Article
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2022, v. 61, n. 7, p. 2969, doi. 10.1093/rheumatology/keab846
- By:
- Publication type:
- Article
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
- Published in:
- Rheumatology, 2022, v. 61, p. SI143, doi. 10.1093/rheumatology/keac249
- By:
- Publication type:
- Article
Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM).
- Published in:
- Rheumatology, 2022, v. 61, p. SI48, doi. 10.1093/rheumatology/keab833
- By:
- Publication type:
- Article
Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2134, doi. 10.1093/rheumatology/keaa371
- By:
- Publication type:
- Article
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1839, doi. 10.1093/rheumatology/keaa429
- By:
- Publication type:
- Article
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 829, doi. 10.1093/rheumatology/keaa436
- By:
- Publication type:
- Article
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
- Published in:
- Rheumatology, 2018, v. 57, n. 11, p. 1956, doi. 10.1093/rheumatology/key190
- By:
- Publication type:
- Article
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria--methodological aspects.
- Published in:
- Rheumatology, 2017, v. 56, n. 11, p. 1884, doi. 10.1093/rheumatology/kex226
- By:
- Publication type:
- Article
Environmental factors associated with disease flare in juvenile and adult dermatomyositis.
- Published in:
- Rheumatology, 2017, v. 56, n. 8, p. 1342, doi. 10.1093/rheumatology/kex162
- By:
- Publication type:
- Article
CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ς-chain expression in T cells.
- Published in:
- Rheumatology, 2017, v. 56, n. 3, p. 467, doi. 10.1093/rheumatology/kew405
- By:
- Publication type:
- Article
Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients.
- Published in:
- Rheumatology, 2016, v. 55, n. 9, p. 1673, doi. 10.1093/rheumatology/kew213
- By:
- Publication type:
- Article
Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2016, v. 55, n. 3, p. 441, doi. 10.1093/rheumatology/kev344
- By:
- Publication type:
- Article
Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2010, v. 49, n. 12, p. 2381
- By:
- Publication type:
- Article
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
- Published in:
- Pediatric Rheumatology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12969-022-00684-9
- By:
- Publication type:
- Article
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 14, p. 2471, doi. 10.1093/hmg/ddac019
- By:
- Publication type:
- Article
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 11, p. 1945, doi. 10.1002/art.41390
- By:
- Publication type:
- Article
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 911, doi. 10.1002/art.40060
- By:
- Publication type:
- Article
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 898, doi. 10.1002/art.40064
- By:
- Publication type:
- Article